IO Biotech
IOBT
IOBT
22 hedge funds and large institutions have $4.78M invested in IO Biotech in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$376K | |
| 2 | +$336K | |
| 3 | +$81.9K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$33.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$27.2K |
Top Sellers
| 1 | -$932K | |
| 2 | -$463K | |
| 3 | -$252K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$121K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$104K |